Aprea Therapeutics APRE
NASDAQ APRE
$0.64 +0.01 (+1.19%)
As of: Aug 21, 2026 · 3:59 PM EDT

Aprea Therapeutics (APRE) Property, Plant & Equipment (Net) (2018 - 2026)

Aprea Therapeutics (APRE) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Aprea Therapeutics 34.25 Mn 34.25 Mn - 64,033.00

Historic Data

Download Data
DateValue
Jun 30, 2026 64,033.00
Jun 30, 2026 64,033.00
Mar 31, 2026 54,379.00
Mar 31, 2026 54,379.00
Dec 31, 2025 59,807.00
Dec 31, 2025 59,807.00
Sep 30, 2025 65,236.00
Sep 30, 2025 65,236.00
Jun 30, 2025 70,665.00
Jun 30, 2025 70,665.00
Mar 31, 2025 76,093.00
Mar 31, 2025 76,093.00
Dec 31, 2024 81,522.00
Dec 31, 2024 81,522.00
Sep 30, 2024 86,950.00
Sep 30, 2024 86,950.00
Jun 30, 2024 92,379.00
Jun 30, 2024 92,379.00
Mar 31, 2024 90,183.00
Mar 31, 2024 90,183.00